Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for neuromyelitis optica spectrum disorder with anti-MOG antibodies has been reported in the published literature.
No clinical trials have been registered for neuromyelitis optica spectrum disorder with anti-MOG antibodies.
44 publications have been identified in PubMed for neuromyelitis optica spectrum disorder with anti-MOG antibodies. Research spans Case Report / Case Series (48%), Epidemiology / Natural History (20%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 21 | 48% |
Data assembled from 3 of 12 sources · Last updated Sep 21, 2026, 4:53 AM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
9 |
20% |
Research summaries | 6 | 14% |
Testing and diagnosis research | 5 | 11% |
New treatment approaches | 2 | 5% |
Laboratory research | 1 | 2% |
Nouira C (2026). [PMID: 41637903](https://pubmed.ncbi.nlm.nih.gov/41637903/). *Journal francais d'ophtalmologie*. [Case Report / Case Series]
Healey C (2026). [PMID: 41797876](https://pubmed.ncbi.nlm.nih.gov/41797876/). *The British and Irish orthoptic journal*. [Case Report / Case Series]
Kimura A (2026). [PMID: 41564469](https://pubmed.ncbi.nlm.nih.gov/41564469/). *Journal of neuroimmunology*. [Case Report / Case Series]
Jang Y (2026). [PMID: 41870402](https://pubmed.ncbi.nlm.nih.gov/41870402/). *J Neuroophthalmol*. [Epidemiology / Natural History]
Apóstolos-Pereira SL (2026). [PMID: 41965135](https://pubmed.ncbi.nlm.nih.gov/41965135/). *Mult Scler Relat Disord*. [Epidemiology / Natural History]
Duman CK (2026). [PMID: 42146957](https://pubmed.ncbi.nlm.nih.gov/42146957/). *Rom J Ophthalmol*. [Case Report / Case Series]
Fortanet García M (2026). [PMID: 41608319](https://pubmed.ncbi.nlm.nih.gov/41608319/). *Case reports in neurological medicine*. [Case Report / Case Series]
Roszak M (2026). [PMID: 41746891](https://pubmed.ncbi.nlm.nih.gov/41746891/). *Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego*. [Case Report / Case Series]
Alfonso-Cedeño DF (2026). [PMID: 41619449](https://pubmed.ncbi.nlm.nih.gov/41619449/). *Journal of neuroimmunology*. [Case Report / Case Series]
Taha SI (2025). [PMID: 39789036](https://pubmed.ncbi.nlm.nih.gov/39789036/). *Scientific reports*. [Diagnostic / Biomarker]
AI-curated news mentioning neuromyelitis optica spectrum disorder with anti-MOG antibodies
Updated Jan 4, 2023
A singer with neuromyelitis optica spectrum disorder (NMOSD) shares her journey to raise awareness and advocate for accurate diagnosis. Her story highlights the importance of patient voices in the rare disease community.